OMKAR PHARMACHEM LTD. Share Price

OMKAR PHARMACHEM LTD. Share Price

BSE: 532167
|
Pharmaceuticals

₹ 9.21

+0.00 (0.00%)
1D
Last updated 08 Oct, 2026, 11:45 IST
--
0.00% up today
--
1D LOW
1D HIGH

OMKAR PHARMACHEM LTD. Returns Calculator

Volume
--
Average traded price
--
Last traded time
11:45:27 08 Oct
Last traded quantity
99
Circuit
L
H
₹8.75
₹9.67
52-week
L
H
₹7.08
₹29.74
Mkt Cap Cr
9.29
P/E
115.13
P/B
0.25
ROA
0.25%
ROE
0.33%
ROCE
0.45%
Quick Ratio
5.96
EV/EBITDA
75.61
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Omkar Pharmachem outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Omkar Pharmachem appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
GMR Airports Infra94,587.31124.42-27.681.38%-10.6%9.36%0.7321.42
NBCC20,120.4026.796.784.7%23.86%31.75%1.0813.11
CENTRAL MINE P N D INST L14,665.5622.426.4220.07%26.86%34.83%3.3314.41
HORIZON INDUSTRIAL PRKS L14,126.220.01.45-1.52%0.92%1.68%4.280.0
INTL GEMOLOGICAL INST LTD13,332.1321.868.9632.82%38.34%46.69%5.0314.94
RITES9,571.2220.743.577.78%15.3%19.48%1.669.62
Rain Industries7,248.34-147.10.74-0.17%-5.94%5.37%0.996.29
LEAP INDIA LIMITED6,264.430.00.02.89%9.54%8.71%1.080.0
RENTOMOJO LIMITED5,318.1950.9811.7719.51%35.26%17.58%0.5537.43
SIS5,769.9939.362.271.92%13.86%12.77%1.4311.93

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About OMKAR PHARMACHEM LTD.

OMKAR PHARMACHEM LTD. Share Price
ISIN
INE501C01015
Sector Market Cap
₹ 9.29 Cr

Omkar Pharmachem Limited is an India-based company. The Company is engaged in the pharmaceuticals and chemicals business. It also provides management and business support services.

OMKAR PHARMACHEM LTD. Financial Highlights

  • Revenue: OMKAR PHARMACHEM LTD. reported revenue of ₹0.48 crore in FY26 vs ₹0.54 crore in FY25. It showed a decrease of 11.11% on a yearly basis.
  • Operating Profit: OMKAR PHARMACHEM LTD. reported an operating profit of ₹0.16 crore in FY26 vs ₹0.27 crore in FY25. It showed a decrease of 40.74% on a year-on-year basis.
  • Net Profit: OMKAR PHARMACHEM LTD. reported a net profit of ₹0.12 crore in FY26 vs ₹0.20 crore in FY25. It showed a decrease of 40.00% on a yearly basis.

OMKAR PHARMACHEM LTD. Quarterly Result Highlights

  • OMKAR PHARMACHEM LTD. reported revenue of ₹0.09 crore in Jun 2026, compared with ₹0.09 crore in Mar 2026, representing an increase of 0.00% on a quarter-on-quarter (QoQ) basis.
  • OMKAR PHARMACHEM LTD. reported an operating loss of ₹0.01 crore in Jun 2026, compared with ₹0.02 crore in Mar 2026, representing a decrease of 150.00% on a quarter-on-quarter (QoQ) basis.
  • OMKAR PHARMACHEM LTD. reported a loss of ₹0.01 crore in Jun 2026, compared with ₹0.02 crore in Mar 2026, reflecting a decrease of 150.00% on a QoQ basis.
  • The earnings per share (EPS) of OMKAR PHARMACHEM LTD. stood at ₹0.12 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
0.03%
FII
0.00%
Other DII
0.00%
Retail and other
99.97%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
1 day
--
1 week
--
1 month
--
1 year
--
3 years
--
5 years
--
Day
Open / Close
Change %
08 Oct 26
₹9.21 / ₹9.21
-4.95%
07 Oct 26
₹9.69 / ₹9.69
-4.91%
05 Oct 26
₹10.20 / ₹10.19
+4.73%
01 Oct 26
₹9.73 / ₹9.73
0.00%
Show more

OMKAR PHARMACHEM LTD. Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹0.47₹0.54₹0.54₹0.54
Other Income₹0.01₹0.00₹0.00₹0.00
Total Revenue₹0.47₹0.54₹0.54₹0.54
Total Expenses₹0.31₹0.27₹0.29₹0.28
Profit Before Tax₹0.16₹0.27₹0.25₹0.26
Tax₹0.04₹0.07₹0.06₹0.07
Profit After Tax₹0.12₹0.20₹0.19₹0.20
EPS - Basic₹0.12₹0.02₹0.19₹0.20
EPS - Diluted₹0.12₹0.02₹0.19₹0.20

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹0.16₹0.27₹0.25₹0.26
Income before WC changes₹0.17₹0.29₹0.29₹0.31
Change in Assets₹0.06-₹0.04₹0.08-₹0.05
Change in Liabilities₹0.01-₹0.01-₹0.07₹0.01
Change in WC₹0.07-₹0.05₹0.01-₹0.04
Cash flow from Operations₹0.23₹0.24₹0.30₹0.28
Cash flow from Investing₹0.00₹0.00-₹0.01₹0.00
Cash flow from Financing-₹0.12-₹0.20-₹0.35-₹0.35
Total Cash Flow₹0.11₹0.04-₹0.06-₹0.08
Cash (Start of the year)₹0.11₹0.07₹0.13₹0.21
Cash (End of the year)₹0.22₹0.11₹0.07₹0.13

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹36.39₹9.34₹9.41₹9.47
Current Assets₹0.30₹0.27₹0.18₹0.26
Total Assets₹36.69₹9.60₹9.59₹9.73
Current Liabilities₹0.05₹0.17₹0.36₹0.69
Net Current Asset₹0.25₹0.10-₹0.18-₹0.42
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹36.64₹9.43₹9.23₹9.04
Total Equity & Liabilities₹36.69₹9.60₹9.59₹9.73
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
9.17
500
9.2
5
9.21
1317
9.6
9080
0
0
Bid Total: 0
Ask Total: 10902
Buy orders: 0%
Sell orders: 100%
Bearish
1
Neutral
6
Bullish
1
Neutral
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
41.7
Neutral
ATR (14)
0.43
Neutral
STOCH(9,6)
27.87
Neutral
STOCH RSI (14)
71.96
Neutral
ADX(9)
27.7
Bearish
UO(9)
46.55
Neutral
ROC(12)
21.18
Bullish
WillR(14)
-39.88
Neutral
Period
Simple value
Exponential vaue
5D
9.71
9.58
10D
9.56
9.44
20D
8.75
9.55
50D
11.72
11.38
100D
16.75
0
Volume trend — traded volume by day
8 Oct0L
7 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
OMKAR PHARMACHEM LTD. Share Price
OMKAR PHARMACHEM LTD.
Pharmaceuticals
Add Stock
Add Another

OMKAR PHARMACHEM LTD. Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.